Abstract
The aim of the CASTEL, a population-based (n = 3282) prospective study which began 14 years ago, was to identify those items which had a prognostic impact in the elderly, and to evaluate whether the typical cardiovascular risk factors, particularly arterial hypertension, play a role after the age of 65 years. Initial screening, final follow-up and annual detection of mortality were performed. Mantel–Hanszel approach and multivariate Cox model were used for statistics. Cardiovascular mortality was 23.3% in normotensive, 23.3% in borderline, and 25% in the sustained hypertensive subjects (insignificant difference). In women, the incidence of stroke and coronary artery disease weakly depended on pulse pressure. Historical stroke and myocardial infarction predicted cardiovascular mortality in women; diabetes, uricaemia and high heart rate in men. In the very old, the predictors were less numerous, and blood pressure was not a predictor whatsoever; pulse blood pressure and murmurs at the neck were especially predictive in women, historical heart failure, proteinuria and tachycardia in men, historical stroke and myocardial infarction, pulmonary disease, left ventricular hypertrophy, diabetes and uricaemia in both genders. The elderly have a different cardiovascular risk pattern compared to younger people. Hypertension is not a predictor of coronary and stroke mortality. Prognosis depends on pulse pressure rather than on the label ‘hypertension’. Hypercholesterolaemia is not a risk factor. This could simply indicate that elderly persons are the survivors in a population where significant mortality has already made its mark, eliminating those with the worst risk pattern. The two genders have a different risk profile due to sex-specific susceptibility to risk factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kannel WB, Castelli WP, McNamara PM . Role of blood pressure in the development of congestive heart failure: the Framingham study N Engl J Med 1972 287: 781–787
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Influence of age, diastolic pressure and prior cardiovascular disease; further analysis of side-effects Circulation 1972 45: 999–1004
Rowland ML, Fulwoold R . Coronary heart disease risk factor trends in blacks between the first and second National Health and Nutrition Examination Surveys, United States, 1971–1980 Am Heart J 1984 108: 771–778
Report by the Management Committee. The Australian Therapeutic Trial in Mild Hypertension Lancet 1980 1: 1261–1267
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. Reduction in mortality of persons with high blood pressure, including mild hypertension JAMA 1979 242: 2562–2571
Luepker RV et al. Population risk of cardiovascular disease: the Minnesota Heart Survey J Chron Dis 1985 38: 671–682
Amery A et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial Lancet 1985 1: 1349–1354
Coope J, Warrender TS . Randomised trial of treatment of hypertension in elderlypatients in primary care Br Med J 1986 293: 1145–1148
Simons LA, Friedlander Y, McCallum J, Simons J . Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly Atherosclerosis 1995 117: 107–118
Zimetbaum P et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study Arterioscler Thromb 1992 12: 416–423
Staessen JA et al. Treatment of isolated systolic hypertension in the elderly: further evidence from thesystolic hypertension in Europe (Syst-Eur) trial Am JCardiol 1998 82: 20–22R
The HOT Study Group. The hypertension optimal treatment study Blood Press 1993 2: 62–68
Palatini P et al. Optimizing the assessment of the elderlypatients with borderline hypertension: the Hypertension and Ambulatory Recording in the OLD (HAROLD) study Aging 1997 9: 365–371
Medical Research Council trial of treatment of hypertension in older adults: principal results MRC Working Party. BMJ 1992 304: 405–412
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991 265: 3255–3264
Casiglia E et al. The CASTEL project (Cardiovascular Study in Elderly): protocol, study design, and preliminary results of the initial survey Cardiologia 1991 36: 569–576
Cherniack RM, Raber MB . Normal standard for ventilatory function using an automated wedge spirometer Ann Rev Resp Dis 1972 106: 38–46
Devereux RB . Evaluation of cardiac structure and function by echocardiography and other noninvasive techniques. In: Laragh JH, Brenner BM (eds) Hypertension: Pathophysiology, Diagnosis, and Management Raven Press: New York 1990 pp 1479–1491
Casiglia E et al. Effects of two different therapeutic approaches on total and cardiovascular mortality in the cardiovascular study in the elderly (CASTEL) Jpn Heart J 1994 35: 589–600
Tate RB, Manfreda J, Cuddy TE . The effect of age on risk factors for ischemic heart disease: the Manitoba Follow-Up Study, 1948–1993 Ann Epidemiol 1998 8: 415–421
Whisnant JP . Effectiveness versus efficacy of treatment of hypertension for stroke prevention Neurology 1996 46: 301–307
Vokonas PS, Kannel WB, Cupples LA . Epidemiology and risk of hypertension in the elderly: the Framingham Study J Hypertens 1988 6: 3–9
Kannel WB, Vokonas PSS . Primary risk factors for coronary heart disease in the elderly: The Framingham study. In: Wenger NK, Furberg CP, Pitt E (eds) Coronary Heart Disease in the Elderly Elsevier Science Publishers: New York 1986 60–82
Howard G et al. Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts. The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) investigators Stroke 1997 28: 1693–1701
Kannel WB . Hypertension as a risk factor for cardiac events. Epidemiologic results of long-term studies J Cardiovasc Pharmacol 1993 21: 27–37
Ekbom T et al. Blood pressure does not predict mortality in the elderly J Hypertens 1988 6: 626–628
Langer RD, Ganiats TG, Barrett-Connor E . Paradoxical survival of elderly men with high blood pressure Br Med J 1989 298: 1356–1358
Mattila K, Haavisto M, Rajala S, Heikinheimo R . Blood pressure and five year survival in the very old Br Med J 1988 296: 887–889
Langer RD, Ganiats TG, Barrett-Connor E . Factors associated with paradoxical survival at higher blood pressures in the very old Am J Epidemiol 1991 134: 29–38
Chae CU et al. Increased pulse pressure and risk of heart failure in the elderly JAMA 1999 281: 634–639
James MA et al. Pulse pressure and resistance artery structure in the elderly Hypertension 1995 26: 301–306
Safar ME, Cloarec-Blanchard L, London GM . Arterial alterations in hypertension with a disproportionate increase in systolic over diastolic blood pressure J Hypertens 1996 14: 103–109
Lee ML, Rosner BA, Weiss ST . Relationship of blood pressure to cardiovascular death: the effects of pulse pressure in the elderly Ann Epidemiol 1999 9: 101–107
Chen YT et al. Risk factors for heart failure in the elderly: a prospective community-based study Am J Med 1999 106: 605–612
Jonason T et al. Menopause is associated with the stiffness of the common carotid artery in 50-year-old women Clin Physiol 1998 18: 149–55
Casiglia E, Palatini P . Cardiovascular risk factors in the elderly J Hum Hyperters 1998 12: 575–581
Meredith PA . Implications of the links between hypertension and MI for choice of drug therapy inpatients with hypertension Am Heart J 1996 132: 222–228
Israili ZH, Hall WD . ACE inhibitors. Differential use in elderlypatients with hypertension Drugs Aging 1995 7: 355–371
Williamson DR, Pharand C . Statins in the prevention of coronary heart disease Pharmacotherapy 1998 18: 242–254
Smith SC Jr . Review of recent clinical trials of lipid lowering in coronary artery disease Am J Cardiol 1997 80: 10H–13H
Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG . Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors Stroke 1997 28: 946–950
Perry HM Jr et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study Stroke 1989 20: 4–13
Dahlof B et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet 1991 338: 1281–1285
Coope J, Warrender TS . Randomised trial of treatment of hypertension in elderlypatients in primary care Br Med J 1986 293: 1145–1151
Gueyffier F et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group Lancet 1999 353: 793–796
Staessen J . The determinants and prognostic significance of serum uric acid in elderlypatients of the European Working Party on High Blood Pressure in the Elderly trial Am J Med 1991 90: 50–54
Wang JG et al. Prognostic significance of serum creatinine and uric acid in older Chinesepatients with isolated systolic hypertension Hypertension 2001 37: 1069–1074
The coronary Drug Project Group. Serum uric acid: its association with other risk factors and with mortality in coronary heart disease J Chronic Dis 1976 29: 557–569
Persky VW et al. Uric acid: a risk factor for coronary heart disease? Circulation 1979 59: 969–977
Woo J et al. Cardiovascular risk factors and 18-month mortality and morbidity in an elderly Chinese population aged 70 years and over Gerontology 1998 44: 51–55
Browner WS, Pressman AR, Lui LY, Cummings SR . Association between serum fructosamine and mortality in elderly women: the study of osteoporotic fractures Am J Epidemiol 1999 149: 471–475
Simons LA, McCallum J, Friedlander Y, Simons J . Predictors of mortality in the prospective Dubbo study of Australian elderly Aust NZJ Med 1996 26: 40–48
Stengard JH et al. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study Diabetologia 1992 35: 760–765
Gillum RF, Makuc DM, Feldman JJ . Pulse rate, coronary heart disease, and death: The NHANES I epidemiologic follow-up study Am Heart J 1991 121: 172–177
Dyer AR et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies Am J Epidemiol 1980 112: 736–749
Palatini P, Julius S . Heart rate and the cardiovascular risk J Hypertens 1997 15: 3–17
Palatini P, Casiglia E, Julius S, Pessina AC . High heart rate. A risk factor for cardiovascular death in elderly men Arch Int Med 1999 159: 585–592
Casiglia E et al. Left ventricular hypertrophy in the elderly: unreliability of electrocardiographic criteria in 477 subjects ages 65 years or more. The cardiovascular study in the elderly (CASTEL) Cardiology 1996 87: 429–435
Mazza A, Casiglia E, Scarpa R, Pessina AC . Prognostic value of proteinuria in elderly subjects with normal renal function High Blood Press 1997 6: 1–7
Ruilope LM . The kidney as part of the cardiovascular system J Cardiovasc Pharmacol 1999 33: 7–10
Jedrychowski W, Maugeri U, Gomola K, Tobiasz-Adamczyk B . Ventilatory lung function level as a predictor of survival among the elderly Arch Chest Dis 1994 49: 293–297
La Rosa JC . Dyslipoproteinemia in women and the elderly Med Clin North Am 1994 78: 163–180
Staessen J et al. Is high serum cholesterol level associated with longer survival in elderly hypertensives? J Hypertens 1990 8: 755–760
Winder AF et al. Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease J Clin Pathol 1996 49: 278–283
Smith GD, Shipley MS, Marmot MG, Rose G . Plasma cholesterol concentration and mortality. The Whitehall Study JAMA 1992 267: 70–76
Menotti A et al. Short-term all-cause mortality and its determinants in elderly male population in Finland, the Netherlands, and Italy: the FINE Study. Finland, Italy, Netherlands Elderly Study Prev Med 1996 25: 319–326
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Casiglia, E., Mazza, A., Tikhonoff, V. et al. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J Hum Hypertens 16, 21–31 (2002). https://doi.org/10.1038/sj.jhh.1001288
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001288
Keywords
This article is cited by
-
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study
Journal of Human Hypertension (2022)
-
RIFLE classification in geriatric patients with acute kidney injury in the intensive care unit
Clinical and Experimental Nephrology (2016)
-
Walking speed and high blood pressure mortality risk in a Spanish elderly population
Journal of Human Hypertension (2015)
-
Opsporing en behandeling van hypertensie bij 80-plussers
Huisarts en wetenschap (2010)
-
Electrocardiographic criteria of left ventricular hypertrophy in general population
European Journal of Epidemiology (2008)